Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease

Journal of the Neurological Sciences

Volumn 247, Issue 2, 2006, Pages 224-230

  Swerdlow, Russell H ^a   Weaver, Bradley ^a   Grawey, Amy ^a   Wenger, Connie ^a   Freed, Eric ^a   Worrall, Bradford B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Complex I; Electron transport chain; Mitochondria; Mitochondrial DNA; Parkinson's disease; Polymorphisms

Indexed keywords

GLYCINE TRANSFER RNA; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; EXON; FAMILY HISTORY; FEMALE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOME ANALYSIS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ELECTRON TRANSPORT COMPLEX I; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; VARIATION (GENETICS); VIRGINIA;

EID: 33748137342     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.05.053     Document Type: Article

References (36)

1. Schapira A.H.V., Cooper J.M., Dexter D., Jenner P., Clark J.B., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet i (1989) 1289
2. Parker W.D., Boyson S.J., and Parks J.K. Electron transport chain abnormalities in idiopathic Parkinson's disease. Ann Neurol 26 (1989) 719-723
3. Langston J.W., Ballard P.A., Tetrud J.W., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
4. Nicklas W.J., and Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36 (1985) 2503-2508
5. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., and Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 80 (1983) 4546-4550
6. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3 (2000) 1301-1306
7. Carroll J., Fearnley I.M., Shannon R.J., Hirst J., and Walker J.E. Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol Cell Proteomics 2 (2003) 117-126
8. Shoffner J.M., Brown M.D., Torroni A., Lott M.T., Cabell M.F., Mirra S.S., et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17 (1993) 171-184
9. Egensperger R., Kosel S., Schnopp N.M., Mehraein P., and Graeber M.B. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. Neuropathol Appl Neurobiol 23 (1997) 315-321
10. Kosel S., Lucking C.B., Egensperger R., Mehraein P., and Graeber M.B. Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism. J Neurosci Res 44 (1996) 174-183
11. Hattori N., Yoshino H., Tanaka M., Suzuki H., and Mizuno Y. Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. Genomics 49 (1998) 52-58
12. Kirchner S.C., Hallagan S.E., Farin F.M., Dilley J., Costa-Mallen P., Smith-Weller T., et al. Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease. Neurotoxicology 21 (2000) 441-445
13. Ross O.A., McCormack R., Maxwell L.D., Duguid R.A., Quinn D.J., Barnett Y.A., et al. mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish. Exp Gerontol 38 (2003) 397-405
14. Otaegui D., Paisan C., Saenz A., Marti I., Ribate M., Marti-Masso J.F., et al. Mitochondrial polymporphisms in Parkinson's Disease. Neurosci Lett 370 (2004) 171-174
15. van der Walt J.M., Nicodemus K.K., Martin E.R., Scott W.K., Nance M.A., Watts R.L., et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72 (2003) 804-811
16. Mayr-Wohlfart U., Rodel G., and Hennesberg A. Mitochondrial tRNA (Gln) and tRNA (Thr) gene variants in Parkinson's disease. Eur J Med Res 2 (1997) 111-113
17. Garcia-Lozano J.R., Mir P., Alberca R., Aguilera I., Gil Neciga E., Fernandez-Lopez O., et al. Mitochondrial DNA A4336G mutation in Alzheimer's and Parkinson's diseases. Eur Neurol 48 (2002) 34-36
18. Tan E.K., Chai A., Zhao Y., Lum S.Y., Fook-Chong S.M., Teoh M.L., et al. Mitochondrial complex I polymorphism and cigarette smoking in Parkinson's disease. Neurology 59 (2002) 1288-1289
19. Bandmann O., Sweeney M.G., Daniel S.E., Marsden C.D., and Wood N.W. Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease. J Neurol 244 (1997) 262-265
20. Simon D.K., Mayeux R., Marder K., Kowall N.W., Beal M.F., and Johns D.R. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology 54 (2000) 703-709
21. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 185-188
22. Tanner C.M., and Goldman S.M. Epidemiology of Parkinson's disease. Neurol Clin 14 (1996) 317-335
23. Swerdlow R.H., Parker Jr. W.D., Currie L.J., Bennett J.P., Harrison M.B., Trugman J.M., et al. Gender ratio differences between Parkinson's disease patients and their affected relatives. Parkinsonism Relat Disord 7 (2001) 129-133
24. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., et al. Sequence and organization of the human mitochondrial genome. Nature 290 (1981) 457-465
25. Martin W.E., Young W.I., and Anderson V.E. Parkinson's disease: a genetic study. Brain 96 (1973) 495-506
26. Payami H., Larsen K., Bernard S., and Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 36 (1994) 659-661
27. Bonifati V., Fabrizio E., Vanacore N., De Mari M., and Meco G. Familial Parkinson's disease: a clinical genetic analysis. Can J Neurol Sci 22 (1995) 272-279
28. Marder K., Tang M.X., Mejia H., Alfaro B., Cote L., Louis E., et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 47 (1996) 155-160
29. Uitti R.J., Shinotoh H., Hayward M., Schulzer M., Mak E., and Calne D.B. "Familial Parkinson's disease": a case-control study of families. Can J Neurol Sci 24 (1997) 127-132
30. Elbaz A., Grigoletto F., Baldereschi M., Breteler M.M., Manubens-Bertran J.M., Lopez-Pousa S., et al. Familial aggregation of Parkinson's disease: a population based case-control study in Europe. Neurology 52 (1999) 1876-1882
31. Taylor C.A., Saint-Hilaire M.H., Cupples L.A., Thomas C.A., Burchard A.E., Feldman R.G., et al. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 88 (1999) 742-749
32. Autere J.M., Moilanen J.S., Myllyla V.V., and Majamaa K. Familial aggregation of Parkinson's disease in a Finnish population. J Neurol Neurosurg Psychiatry 69 (2000) 107-109
33. Elbaz A., McDonnell S.K., Maraganore D.M., Strain K.J., Schaid D.J., Bower J.H., et al. Validity of family history data on PD: evidence for a family information bias. Neurology 61 (2003) 11-17
34. Marder K., Levy G., Louis E.D., Mejia-Santana H., Cote L., Andrews H., et al. Accuracy of family history data on Parkinson disease. Neurology 61 (2003) 18-23
35. Tanner C.M. PD or not PD? That is the question. Neurology 61 (2003) 5-6
36. Brandon M.C., Lott M.T., Nguyen K.C., Spolim S., Navathe S.B., Baldi P., et al. MITOMAP: a human mitochondrial genome database-2004 update. Nucleic Acids Res (2005) 33 [Database Issue: D611-13]